X @Forbes

Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into treatments for Alzheimer’s disease and expand into immune diseases.https://t.co/QiTtfEYSjy https://t.co/XdRh7oCqF8 ...